Dr Reddy's Bachupally biologics facility gets USFDA Form 483 with 9 observations

On Thursday, Dr. Reddy's Laboratories, a prominent pharmaceutical company, disclosed to the stock exchanges that it has been issued a Form 483 containing nine observations by the US Food & Drug Administration (FDA), the regulatory body in the United States. These observations pertain to its biologics manufacturing facility...